These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
255 related items for PubMed ID: 26067713
1. A pathological scoring system to predict renal outcome in diabetic nephropathy. Hoshino J, Mise K, Ueno T, Imafuku A, Kawada M, Sumida K, Hiramatsu R, Hasegawa E, Yamanouchi M, Hayami N, Suwabe T, Sawa N, Hara S, Fujii T, Ohashi K, Ubara Y, Takaichi K. Am J Nephrol; 2015; 41(4-5):337-44. PubMed ID: 26067713 [Abstract] [Full Text] [Related]
2. Value of adding the renal pathological score to the kidney failure risk equation in advanced diabetic nephropathy. Yamanouchi M, Hoshino J, Ubara Y, Takaichi K, Kinowaki K, Fujii T, Ohashi K, Mise K, Toyama T, Hara A, Kitagawa K, Shimizu M, Furuichi K, Wada T. PLoS One; 2018; 13(1):e0190930. PubMed ID: 29338014 [Abstract] [Full Text] [Related]
3. Renal histology in diabetic nephropathy predicts progression to end-stage kidney disease but not the rate of renal function decline. Misra PS, Szeto SG, Krizova A, Gilbert RE, Yuen DA. BMC Nephrol; 2020 Jul 18; 21(1):285. PubMed ID: 32682403 [Abstract] [Full Text] [Related]
4. Histological predictors for renal prognosis in diabetic nephropathy in diabetes mellitus type 2 patients with overt proteinuria. Okada T, Nagao T, Matsumoto H, Nagaoka Y, Wada T, Nakao T. Nephrology (Carlton); 2012 Jan 18; 17(1):68-75. PubMed ID: 21933307 [Abstract] [Full Text] [Related]
5. Clinical and pathological predictors of estimated GFR decline in patients with type 2 diabetes and overt proteinuric diabetic nephropathy. Mise K, Hoshino J, Ueno T, Hazue R, Sumida K, Hiramatsu R, Hasegawa E, Yamanouchi M, Hayami N, Suwabe T, Sawa N, Fujii T, Hara S, Ohashi K, Takaichi K, Ubara Y. Diabetes Metab Res Rev; 2015 Sep 18; 31(6):572-81. PubMed ID: 25533683 [Abstract] [Full Text] [Related]
6. Glomerular basement membrane duplication is a predictor of the prognosis of diabetic nephropathy in patients with type 2 diabetes. Yamakawa T, Kawaguchi T, Kitamura H, Kadomura M, Nishimura M, Yokoo T, Imasawa T. Clin Exp Nephrol; 2019 Apr 18; 23(4):521-529. PubMed ID: 30467801 [Abstract] [Full Text] [Related]
7. Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy. Hwang S, Park J, Kim J, Jang HR, Kwon GY, Huh W, Kim YG, Kim DJ, Oh HY, Lee JE. J Diabetes Complications; 2017 Dec 18; 31(12):1704-1709. PubMed ID: 29037450 [Abstract] [Full Text] [Related]
8. Prognostic Value of Tubulointerstitial Lesions, Urinary N-Acetyl-β-d-Glucosaminidase, and Urinary β2-Microglobulin in Patients with Type 2 Diabetes and Biopsy-Proven Diabetic Nephropathy. Mise K, Hoshino J, Ueno T, Hazue R, Hasegawa J, Sekine A, Sumida K, Hiramatsu R, Hasegawa E, Yamanouchi M, Hayami N, Suwabe T, Sawa N, Fujii T, Hara S, Ohashi K, Takaichi K, Ubara Y. Clin J Am Soc Nephrol; 2016 Apr 07; 11(4):593-601. PubMed ID: 26801478 [Abstract] [Full Text] [Related]
9. Renal pathological implications in type 2 diabetes mellitus patients with renal involvement. Li L, Zhang X, Li Z, Zhang R, Guo R, Yin Q, Yang L, Yue R, Su B, Huang S, Xu H, He C, Liu F. J Diabetes Complications; 2017 Jan 07; 31(1):114-121. PubMed ID: 27838100 [Abstract] [Full Text] [Related]
12. Renal prognosis a long time after renal biopsy on patients with diabetic nephropathy. Mise K, Hoshino J, Ubara Y, Sumida K, Hiramatsu R, Hasegawa E, Yamanouchi M, Hayami N, Suwabe T, Sawa N, Fujii T, Ohashi K, Hara S, Takaichi K. Nephrol Dial Transplant; 2014 Jan 07; 29(1):109-18. PubMed ID: 24151019 [Abstract] [Full Text] [Related]
13. Clinico-pathological characteristics and outcomes of patients with biopsy-proven hypertensive nephrosclerosis: a retrospective cohort study. Liang S, Le W, Liang D, Chen H, Xu F, Chen H, Liu Z, Zeng C. BMC Nephrol; 2016 Apr 11; 17():42. PubMed ID: 27066888 [Abstract] [Full Text] [Related]
14. Serum transferrin predicts end-stage Renal Disease in Type 2 Diabetes Mellitus patients. Zhao L, Zou Y, Zhang J, Zhang R, Ren H, Li L, Guo R, Zhang J, Liu F. Int J Med Sci; 2020 Apr 11; 17(14):2113-2124. PubMed ID: 32922172 [Abstract] [Full Text] [Related]
15. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China. Lv J, Zhang H, Zhou Y, Li G, Zou W, Wang H. Nephrology (Carlton); 2008 Jun 11; 13(3):242-6. PubMed ID: 18221258 [Abstract] [Full Text] [Related]
16. A novel simpler histological classification for renal survival in IgA nephropathy: a retrospective study. Manno C, Strippoli GF, D'Altri C, Torres D, Rossini M, Schena FP. Am J Kidney Dis; 2007 Jun 11; 49(6):763-75. PubMed ID: 17533019 [Abstract] [Full Text] [Related]
17. Plasma D-dimer levels are associated with disease progression in diabetic nephropathy: a two-center cohort study. Yu Y, Zhu C, Lin Y, Qian Q, Shen X, Zou W, Wang M, Gong J, Chen M, Liu L, Yu R, Shen Q, Shao L, Zhu B. Ren Fail; 2023 Jun 11; 45(2):2285868. PubMed ID: 38013428 [Abstract] [Full Text] [Related]
18. Nonproteinuric Versus Proteinuric Phenotypes in Diabetic Kidney Disease: A Propensity Score-Matched Analysis of a Nationwide, Biopsy-Based Cohort Study. Yamanouchi M, Furuichi K, Hoshino J, Toyama T, Hara A, Shimizu M, Kinowaki K, Fujii T, Ohashi K, Yuzawa Y, Kitamura H, Suzuki Y, Sato H, Uesugi N, Hisano S, Ueda Y, Nishi S, Yokoyama H, Nishino T, Samejima K, Kohagura K, Shibagaki Y, Mise K, Makino H, Matsuo S, Ubara Y, Wada T, Research Group of Diabetic Nephropathy, the Ministry of Health, Labour and Welfare, and the Japan Agency for Medical Research and Development. Diabetes Care; 2019 May 11; 42(5):891-902. PubMed ID: 30833372 [Abstract] [Full Text] [Related]
20. Association between serum alkaline phosphatase and renal outcome in patients with type 2 diabetes mellitus. Zhao L, Li L, Ren H, Zou Y, Zhang R, Wang S, Xu H, Zhang J, Liu F. Ren Fail; 2020 Nov 11; 42(1):818-828. PubMed ID: 32781868 [Abstract] [Full Text] [Related] Page: [Next] [New Search]